Psychiatry News

NEW YORK — In this Healio Video Perspective, Reid Robison, MD, MBA, senior principal investigator at Numinus, a company that conducts clinical trials in psychedelics, discusses promising new treatment options for psychiatric conditions.

Lantheus Holdings Inc. has announced the acquisition of Meilleur Technologies Inc., which includes the transfer of its rights to an amyloid-beta positron emission tomography imaging agent.

Autism spectrum disorder incidence was higher for children with prenatal exposure to antiseizure medications vs. the general population, but some associations weakened after adjusting for treatment indication, researchers reported.

Semaglutide was not associated with increased risks for adverse neurologic or psychological disorders at 1 year compared with other diabetes drugs, according to data published in eClinicalMedicine.

Patients with breast cancer who reported high burdens of pain and stress had poorer outcomes than those with lower pain or stress levels, according to research presented at ASCO Annual Meeting.

Johnson & Johnson announced that it has submitted a supplemental new drug application for the approval of esketamine nasal spray as a monotherapy for adults with treatment-resistant depression.

The NIH announced that it has invested $30 million over 2024 and 2025 to pilot a national primary care research network that will integrate clinical research into community-based primary care.

NEW YORK — In this Healio Video Perspective from the American Psychiatric Association Annual Meeting, Stefanie Simmons, MD, FACEP, chief medical officer of the Dr. Lorna Breen Heroes’ Foundation, discusses the Frontline Connect toolkit.

The FDA has granted fast-track designation to a proprietary, scalable, allogeneic, investigational cellular therapy in development to address symptoms of mild Alzheimer’s disease, according to the manufacturer.

The Savings on a Valuable Education (SAVE) plan was introduced in 2023 by the Biden Administration and replaces the Revised Pay As You Earn (REPAYE) program. SAVE continues to evolve with new benefits for student loan borrowers.